Top Pharmaceutical Companies in Tampa, FL (15)
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for...
Pfizer's Top Stability & Growth Strengths
Product Line Growth: Growth across non‑COVID medicines such as Eliquis, Padcev, the Vyndaqel family, Lorbrena, Nurtec/Vydura and oncology biosimilars has been robust. Launched and acquired products are showing sustained double‑digit operational gains, adding meaningful momentum.
Resilient & Sustainable Growth: Excluding COVID products, the underlying portfolio delivered mid‑single‑digit operational growth in 2025 and continued at a similar pace in early 2026, more than offsetting part of the COVID‑related decline. Reported revenue also returned to modest year‑over‑year growth in the first half of 2026, indicating stabilization.
Future-Ready Strategy: Management raised the midpoint of 2026 revenue guidance and continues to invest heavily in a broad late‑stage pipeline. This posture signals confidence that newer launches and acquired assets can drive the next leg of growth.
Our mission is to improve health outcomes through behavior change at the point of care and beyond. Every day, people make choices that shape their health, and at PatientPoint, we strive to support those decisions with the right information delivered at the right time. We're proud to power the largest network of digital devices in doctor's offices across the country —...
PatientPoint's Top Stability & Growth Strengths
Strong Revenue Growth: Top-line revenue is reported to have grown strongly on a multi-year basis through 2023, with additional indications of continued increases into 2025–2026. This provides the clearest quantitative signal of momentum for a private company with limited disclosures.
Market Expansion: The provider network and product footprint have broadened, including new launches such as programmatic access and a consumer health media offering alongside partnerships that extend reach. These moves show growth beyond core point-of-care screens into adjacent adtech and consumer channels.
Investor Backing & Capital Strength: Advent International’s 2025 agreement to acquire the company and continued investment signal substantial sponsor support for scaling. Such backing typically underwrites further network growth and product innovation.
At Lonza, we enable A Healthier World by supporting our healthcare customers on the path to commercialization. Our community of 16,000 talented employees work across a global network of more than 30 sites to deliver for our customers across the pharma, biotech and nutrition markets.
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and...
Catalent, Inc.'s Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent analyses consistently place Catalent among the top global CDMOs, with meaningful presence in outsourced finished‑dose approvals and a broad end‑to‑end network. Its scale across oral, sterile, biologics, and cell & gene therapy supports late‑stage and commercial programs globally.
Investor Backing & Capital Strength: Novo Holdings’ completed acquisition provides deep‑capital sponsorship and strategic validation, with U.S./EU clearance reinforcing the platform’s importance. Related transactions around sterile sites highlight the strategic value of capabilities aligned to high‑demand medicines.
Future-Ready Strategy: Private ownership and a refreshed operating model aim to focus investment on biologics, cell & gene therapy, and clinical supply. GLP‑1–linked demand signals and capacity plans into the coming years indicate preparedness for sustained growth.
“We are a part of the circle of life. It’s as touching and important to be a part of the end of life as it is to be at the beginning. We provide our patients dignity, comfort and quality of life at the end of their journey. Our job is so much more about life than death! Being present during...
AnazaoHealth Corporation is a pharmaceuticals company that provides pain management services.
Advanced Rx is a physician-driven pharmacy services company specializing in mail-order pharmacy, in-office dispensing, and wholesale repackaging. They provide streamlined medication solutions and Revenue Cycle Management (RCM) for healthcare providers, particularly for Workers' Compensation and Personal Injury cases, to reduce administrative burdens and improve patient outcomes.
myMatrixx provides pharmacy benefits management, ancillary benefits management, and clinical management for workers' compensation programs.
Oragenics develops oral probiotic products and antibiotics for humans and companion pets.
Headquartered in Louisville, Kentucky, PharMerica is one of the largest institutional pharmacy companies in the U.S. With more than 180 long-term care pharmacies in almost every state, we offer a national scope with a local approach, as well as unmatched clinical quality and customer care. With approximately 6,000 dedicated employees, PharMerica is proud to be home to some of the industry’s...
PharMerica's Top Stability & Growth Strengths
Strong Market Position & Advantage: PharMerica is widely recognized as a national leader in institutional and long‑term care pharmacy, with a broad footprint and specialized offerings across multiple care settings. Its integration within BrightSpring’s pharmacy platform and extensive distribution network reinforce a durable competitive position.
Market Expansion: The company continues to scale its operational footprint through facility upgrades, added locations, and active hiring in operations and finance. Acquisitions and multi‑state growth initiatives indicate sustained reach across key markets.
Strategic Partnerships: Collaborations with medication‑management and health‑technology providers, including initiatives to improve adherence and rural access, expand service capabilities. Technology integrations with EHR and e‑prescribing systems support clients navigating complex compliance demands.
When you donate blood plasma, you help create life-changing medicines, while putting a little extra money in your pocket at the same time.
Omnicare is a pharmacy services provider for long-term care and post-acute facilities, as well as assisted living or senior living communities.
